{"id":"W3204661301","doi":"10.1158/1078-0432.ccr-21-2160","title":"First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors","year":2021,"lang":"en","type":"article","venue":"Clinical Cancer Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"Merck","keywords":"Pembrolizumab; Immunotherapy; Antibody; Mechanism (biology); Cancer; Mechanism of action; Inflammation; Tumor cells","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006740096,0.0007012098,0.001046161,0.0002096235,0.0002057465,0.00038826,0.0004115679,0.0003625394,0.001437576],"category_scores_gemma":[0.000312089,0.000247235,0.000379613,0.0001755034,0.0004744995,0.0003674722,0.0001914718,0.001484268,0.0003914586],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006231943,"about_ca_system_score_gemma":0.0006571459,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003973348,"about_ca_topic_score_gemma":0.001051138,"domain_scores_codex":[0.9997646,0.0000984718,0.00001482979,0.00003183728,0.0000328795,0.00005737103],"domain_scores_gemma":[0.9997899,0.00003703147,0.00005865902,0.00002357145,0.00001448512,0.00007630156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1114876,0.05682231,0.0240363,0.001077677,0.0008015565,0.0006920582,0.0004522431,0.003783094,0.6218228,0.0003371652,0.002859925,0.1758275],"study_design_scores_gemma":[0.07211865,0.7071362,0.08008467,0.00005766766,0.000653136,0.002729379,0.0001314858,0.004810669,0.1250711,0.0002034982,0.006965833,0.00003772712],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9985683,0.0006706304,0.0001896101,0.00007275636,0.00001579884,0.0001155353,0.00005614616,0.00002060229,0.0002904186],"genre_scores_gemma":[0.998429,0.0004384406,0.0004071698,0.00006214776,0.00003177865,0.00008521384,0.0001563407,0.00000516829,0.0003846266],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001437576,"threshold_uncertainty_score":0.004809141,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05857804920251942,"score_gpt":0.4158119522793154,"score_spread":0.357233903076796,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}